3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
3
Recruiting
3
Completed
2
Withdrawn
1
Enrolling by invitation
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Breast
2
Gynecologic
1
Conditions
Lymphoma, Non-Hodgkin
5
Lymphoma
4
Cardiotoxicity
4
Heart Failure
3
Prostatic Neoplasms
2
Heart Diseases
2
Breast Neoplasms
2
Ventricular Dysfunction, Left
1
Thoracic Neoplasms
1
Small Cell Lung Carcinoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Metastatic Solid Tumors
1
Metabolic Syndrome
1
Memory Disorders
1
Lymphoproliferative Disorders
1
Lymphomatoid Granulomatosis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Leukemia, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Hematologic Neoplasms
1
Epstein-Barr Virus Infections
1
Interventions
Trastuzumab
350
Paclitaxel
334
Cyclophosphamide
315
Docetaxel
291
Capecitabine
181
Doxorubicin
180
Letrozole
166
Tamoxifen
145
Bevacizumab
124
Fulvestrant
118
Carboplatin
118
exemestane
111
Lapatinib
111
Anastrozole
111
Radiotherapy
105
Epirubicin
104
Gemcitabine
97
palbociclib
84
Exercise
78
Vinorelbine
77
Fluorouracil
77
Surveys and Questionnaires
71
pertuzumab
67
Filgrastim
64
Albumin-Bound Paclitaxel
64
eribulin
55
Magnetic Resonance Spectroscopy
55
Everolimus
52
Blood Specimen Collection
51
Zoledronic Acid
50
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Breast Neoplasms
×
Echocardiography
×
Clear all
NCT03510689
2024-10-16
Gene-HEART
Abramson Cancer Center at Penn Medicine
Completed
79 enrolled
NCT03940625
2022-05-25
ANKE
Heinrich-Heine University, Duesseldorf
Phase NA
Completed
69 enrolled